Posts

Fixed combination of palmitoylethanolamide and melatonin in preventive therapy of migraine: results from a randomized clinical trial

Migraines are neurological disorders which significantly impact quality of life. Current pharmacological treatments often have adverse effects, prompting the search for alternatives with fewer side effects. Several studies have described the antimigraine properties of palmitoylethanolamide (PEA) and melatonin.

Perceptions and recommendation behaviors of dermatologists for medical cannabis: A pilot survey

Authors: Samuel Yeroushalmi, Kamaria Nelsona, Andrew Sparks, Adam Friedman Published in Complementary Therapies in Medicine September 2020 Abstract Objectives Evidence suggests that cannabinoids may provide therapeutic benefit to patients with…